Discover QuantumVision™
Revolutionizing Medical Imaging with AI
Revolutionizing Medical Imaging with AI
Revolutionizing Medical Imaging with AI
Revolutionizing Medical Imaging with AI
QuantumVision™ v3.0 is the pinnacle of medical imaging AI technology, designed to revolutionize the healthcare landscape with its state-of-the-art features and unparalleled capabilities.
QuantumVision™ v3.0 is the pinnacle of medical imaging AI technology, designed to revolutionize the healthcare landscape with its state-of-the-art features and unparalleled capabilities.
QuantumVision™ v3.0 is the pinnacle of medical imaging AI technology, designed to revolutionize the healthcare landscape with its state-of-the-art features and unparalleled capabilities.
QuantumVision™ v3.0
Integrating advanced quantum computing principles with cutting-edge artificial intelligence to deliver precise, real-time medical analysis.
QuantumVision™ v3.0
Integrating advanced quantum computing principles with cutting-edge artificial intelligence to deliver precise, real-time medical analysis.
QuantumVision™ v3.0
Integrating advanced quantum computing principles with cutting-edge artificial intelligence to deliver precise, real-time medical analysis.
QuantumVision™ v3.0
Integrating advanced quantum computing principles with cutting-edge artificial intelligence to deliver precise, real-time medical analysis.
The Challenge
The Critical Problem in Medical Imaging
From molecule to biomarker to pathway, the loop transforms images and omics into signal, so teams see more, sooner, and decide with confidence.
Diagnostic Delays
Batch processing systems create delays in diagnosis, preventing real-time clinical decision-making and impacting treatment initiation timelines.
Diagnostic Delays
Batch processing systems create delays in diagnosis, preventing real-time clinical decision-making and impacting treatment initiation timelines.
Diagnostic Delays
Batch processing systems create delays in diagnosis, preventing real-time clinical decision-making and impacting treatment initiation timelines.
Diagnostic Delays
Batch processing systems create delays in diagnosis, preventing real-time clinical decision-making and impacting treatment initiation timelines.
Radiologist Shortage
Single AI model systems lack cross-validation capabilities, increasing the risk of diagnostic errors without independent verification mechanisms.
Radiologist Shortage
Single AI model systems lack cross-validation capabilities, increasing the risk of diagnostic errors without independent verification mechanisms.
Radiologist Shortage
Single AI model systems lack cross-validation capabilities, increasing the risk of diagnostic errors without independent verification mechanisms.
Radiologist Shortage
Single AI model systems lack cross-validation capabilities, increasing the risk of diagnostic errors without independent verification mechanisms.
Rising Imaging Volumes
Limited multi-modal intelligence prevents comprehensive analysis that integrates patient history, symptoms, and imaging data simultaneously.
Rising Imaging Volumes
Limited multi-modal intelligence prevents comprehensive analysis that integrates patient history, symptoms, and imaging data simultaneously.
Rising Imaging Volumes
Limited multi-modal intelligence prevents comprehensive analysis that integrates patient history, symptoms, and imaging data simultaneously.
Rising Imaging Volumes
Limited multi-modal intelligence prevents comprehensive analysis that integrates patient history, symptoms, and imaging data simultaneously.
Diagnostic Variability
Lack of transparent confidence scoring and real-time metrics reduces trust and clarity in AI-generated diagnostic recommendations.
Diagnostic Variability
Lack of transparent confidence scoring and real-time metrics reduces trust and clarity in AI-generated diagnostic recommendations.
Diagnostic Variability
Lack of transparent confidence scoring and real-time metrics reduces trust and clarity in AI-generated diagnostic recommendations.
Diagnostic Variability
Lack of transparent confidence scoring and real-time metrics reduces trust and clarity in AI-generated diagnostic recommendations.
Our Solution
AI-Powered Clinical Excellence
QuantumVision™ v3.0 combines dual AI engines with quantum-inspired analytics to transform medical imaging analysis through real-time streaming, multi-modal intelligence, and comprehensive 7-stage evaluation.
90% Faster
Real-time streaming analysis with progressive report generation, providing instantaneous updates throughout the diagnostic process.
90% Faster
Real-time streaming analysis with progressive report generation, providing instantaneous updates throughout the diagnostic process.
90% Faster
Real-time streaming analysis with progressive report generation, providing instantaneous updates throughout the diagnostic process.
90% Faster
Real-time streaming analysis with progressive report generation, providing instantaneous updates throughout the diagnostic process.
500K+ Images
Dual AI engine architecture with GGF 2.0 for ultra-fast analysis and CS4 for deep differential diagnosis verification.
500K+ Images
Dual AI engine architecture with GGF 2.0 for ultra-fast analysis and CS4 for deep differential diagnosis verification.
500K+ Images
Dual AI engine architecture with GGF 2.0 for ultra-fast analysis and CS4 for deep differential diagnosis verification.
500K+ Images
Dual AI engine architecture with GGF 2.0 for ultra-fast analysis and CS4 for deep differential diagnosis verification.
95%+ Accuracy
Cross-validation between two leading AI models ensuring the highest level of diagnostic accuracy and reliability.
95%+ Accuracy
Cross-validation between two leading AI models ensuring the highest level of diagnostic accuracy and reliability.
95%+ Accuracy
Cross-validation between two leading AI models ensuring the highest level of diagnostic accuracy and reliability.
95%+ Accuracy
Cross-validation between two leading AI models ensuring the highest level of diagnostic accuracy and reliability.
Full Analytics
Quantum-inspired confidence scoring with multi-dimensional analysis encompassing depth, integrity, and reliability metrics.
Full Analytics
Quantum-inspired confidence scoring with multi-dimensional analysis encompassing depth, integrity, and reliability metrics.
Full Analytics
Quantum-inspired confidence scoring with multi-dimensional analysis encompassing depth, integrity, and reliability metrics.
Full Analytics
Quantum-inspired confidence scoring with multi-dimensional analysis encompassing depth, integrity, and reliability metrics.
Platform Capabilities
Advanced Platform Features
Advanced Platform Features
Advanced
Platform Features
Advanced
Platform Features
QuantumVision™ v3.0 offers a comprehensive suite of tools for modern clinical imaging workflows, driving efficiency and better patient care.
QuantumVision™ v3.0 offers a comprehensive suite of tools for modern clinical imaging workflows, driving efficiency and better patient care.
Multi-Modal Analysis
Supports CT, MRI, X-Ray, Ultrasound, and Mammography with specialized AI models for each modality.
Multi-Modal Analysis
Supports CT, MRI, X-Ray, Ultrasound, and Mammography with specialized AI models for each modality.
Multi-Modal Analysis
Supports CT, MRI, X-Ray, Ultrasound, and Mammography with specialized AI models for each modality.
Multi-Modal Analysis
Supports CT, MRI, X-Ray, Ultrasound, and Mammography with specialized AI models for each modality.
Radiomic Features
Extracts 100+ quantitative imaging biomarkers for precise characterization of tissues and lesions, assisting in therapy planning.
Radiomic Features
Extracts 100+ quantitative imaging biomarkers for precise characterization of tissues and lesions, assisting in therapy planning.
Radiomic Features
Extracts 100+ quantitative imaging biomarkers for precise characterization of tissues and lesions, assisting in therapy planning.
Radiomic Features
Extracts 100+ quantitative imaging biomarkers for precise characterization of tissues and lesions, assisting in therapy planning.
Lesion Detection
AI-powered identification and characterization of abnormalities with precise localization and measurement, acting as a "second reader."
Lesion Detection
AI-powered identification and characterization of abnormalities with precise localization and measurement, acting as a "second reader."
Lesion Detection
AI-powered identification and characterization of abnormalities with precise localization and measurement, acting as a "second reader."
Lesion Detection
AI-powered identification and characterization of abnormalities with precise localization and measurement, acting as a "second reader."
Clinical Decision Support
Provides risk stratification and evidence-based recommendations instantly, aligned with established clinical guidelines.
Clinical Decision Support
Provides risk stratification and evidence-based recommendations instantly, aligned with established clinical guidelines.
Clinical Decision Support
Provides risk stratification and evidence-based recommendations instantly, aligned with established clinical guidelines.
Clinical Decision Support
Provides risk stratification and evidence-based recommendations instantly, aligned with established clinical guidelines.
Temporal Comparison
Automated comparison of current and prior studies to accurately track disease progression or evaluate treatment response over time.
Temporal Comparison
Automated comparison of current and prior studies to accurately track disease progression or evaluate treatment response over time.
Temporal Comparison
Automated comparison of current and prior studies to accurately track disease progression or evaluate treatment response over time.
Temporal Comparison
Automated comparison of current and prior studies to accurately track disease progression or evaluate treatment response over time.
EHR Integrationv3.0
Seamless and secure integration with hospital Electronic Health Record (EHR) systems via industry-standard FHIR and DICOM protocols.
EHR Integrationv3.0
Seamless and secure integration with hospital Electronic Health Record (EHR) systems via industry-standard FHIR and DICOM protocols.
EHR Integrationv3.0
Seamless and secure integration with hospital Electronic Health Record (EHR) systems via industry-standard FHIR and DICOM protocols.
EHR Integrationv3.0
Seamless and secure integration with hospital Electronic Health Record (EHR) systems via industry-standard FHIR and DICOM protocols.
Technology
Proprietary Technology Stack
Proprietary
Technology Stack
Built on cutting-edge AI research with robust, secure, and scalable clinical-grade infrastructure.
Python Ecosystem
Python Ecosystem
Python Ecosystem
Python Ecosystem
TensorFlow/PyTorch
TensorFlow/PyTorch
TensorFlow/PyTorch
TensorFlow/PyTorch
Advanced CNNs
Advanced CNNs
Advanced CNNs
Advanced CNNs
HIPAA Compliant
HIPAA Compliant
HIPAA Compliant
HIPAA Compliant
Cloud Native
Cloud Native
Cloud Native
Cloud Native
Multi-Platform
Multi-Platform
Multi-Platform
Multi-Platform
Our Difference
Quantumvision™ vs the world
Quantumvision™ vs the world
Quantumvision™
vs the world
Quantumvision™
vs the world
Built on cutting-edge AI research with robust, secure, and scalable clinical-grade infrastructure.
Built on cutting-edge AI research with robust, secure, and scalable clinical-grade infrastructure.
Built on cutting-edge AI research with robust, secure,
and scalable clinical-grade infrastructure.
Built on cutting-edge AI research with robust, secure, and scalable clinical-grade infrastructure.
Current Methods
Current Methods
Current Methods
Quantumvision™
Image Analysis Time
Radiomic feature extraction
Several days
Minutes
Diagnostic Accuracy
Reduce interpretation errors
Frequently variable
Consistently high (>95% concordance)
Biomarker Extraction
Quantitative imaging biomarkers
Limited/Manual
Limited
/
Manual
Limited
/
Manual
Automated (500+ features)
Multi-Modality Support
MRI, CT, PET, X-ray, ultrasound
Single modality focus
All modalities
Predictive Analytics
Disease progression forecasting
Limited
Validated ML models
Clinical Integration Speed
ACS/EHR workflow deployment
Months
Hours to days
Early Disease Detection
Pre-symptomatic pattern identification
After visible progression
Detects subtle early changes
Longitudinal Tracking
Automated progression modeling
Manual comparison
Automated with change detection
Clinical Workflow Efficiency
Radiologist productivity
Mediocre at best
Significantly enhanced
Our people
Leadership Team
Leadership Team
Leadership
Team
Combining decades of experience in AI, medical imaging, clinical practice, and healthcare business development, our leadership drives innovation from quantum research to patient impact.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
T. Ritchie
Chief Executive Officer
Managing a multi-billion dollar investment fund, 25+ years in business development and leadership.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. Alex F. Metwaly
Co-Founder & Chief Scientific Officer
20+ years in BioTech and AI, Former Chair of National Data Center, 150+ publications in deep learning.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
Dr. F. A. Naftolin
Chief Medical Officer
MD, PhD in Women's Health, Expert in drug design, clinical trials, and healthcare strategy.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
P. Wolfe
Board Head
Managing Partner at top-tier VC firm, 30+ years in strategic technology investments and growth scaling.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
James Wilson
Head of Business Development
Former VP at Siemens Healthineers, 20+ years in medical device commercialization and global sales.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
TBN
Head of Sales (Recruiting)
Candidate search underway for experienced sales leader with deep hospital and health system network.
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Market Opportunity
Massive Market Opportunity
Massive Market Opportunity
Massive
Market Opportunity
Massive
Market Opportunity
Born from the collective ambition of industry veterans and technology innovators, our mission is to expedite the journey of groundbreaking healthcare solutions from conception to global markets.
$4.5B
Global AI Medical Imaging Market (2023)
$4.5B
Global AI Medical Imaging Market (2023)
$4.5B
Global AI Medical Imaging Market (2023)
$4.5B
Global AI Medical Imaging Market (2023)
$45B
Projected Market by 2030 (35% CAGR)
$45B
Projected Market by 2030 (35% CAGR)
$45B
Projected Market by 2030 (35% CAGR)
$45B
Projected Market by 2030 (35% CAGR)
8,000+
Hospitals in US & EU Target Market
8,000+
Hospitals in US & EU Target Market
8,000+
Hospitals in US & EU Target Market
8,000+
Hospitals in US & EU Target Market
$2.5M
Avg. Hospital Imaging Budget (Annual)
$2.5M
Avg. Hospital Imaging Budget (Annual)
$2.5M
Avg. Hospital Imaging Budget (Annual)
$2.5M
Avg. Hospital Imaging Budget (Annual)
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
Confidential Material
This section contains proprietary information intended for potential investors.
The Opportunity
Investment overview
Positioned for the shift from classical to quantum-accelerated discovery.
$
3M
Innovate
Securing capital for product refinement, critical clinical validation studies, and initial strategic market entry.
FDA clearance preparation & filing
Pilot deployments at 5 major hospital systems
Team expansion to 15 full-time members
Clinical validation studies completion
$
3M
Innovate
Securing capital for product refinement, critical clinical validation studies, and initial strategic market entry.
FDA clearance preparation & filing
Pilot deployments at 5 major hospital systems
Team expansion to 15 full-time members
Clinical validation studies completion
$
3M
Innovate
Securing capital for product refinement, critical clinical validation studies, and initial strategic market entry.
FDA clearance preparation & filing
Pilot deployments at 5 major hospital systems
Team expansion to 15 full-time members
Clinical validation studies completion
$
3M
Innovate
Securing capital for product refinement, critical clinical validation studies, and initial strategic market entry.
FDA clearance preparation & filing
Pilot deployments at 5 major hospital systems
Team expansion to 15 full-time members
Clinical validation studies completion
$
10M
Series A (Projected)
Targeted capital for full commercial scaling, regulatory approvals, and platform module expansion.
EU MDR & full FDA 510(k) clearance
Expansion to 50+ hospital systems globally
Development of 3 new specialty AI modules
International market penetration
$
10M
Series A (Projected)
Targeted capital for full commercial scaling, regulatory approvals, and platform module expansion.
EU MDR & full FDA 510(k) clearance
Expansion to 50+ hospital systems globally
Development of 3 new specialty AI modules
International market penetration
$
10M
Series A (Projected)
Targeted capital for full commercial scaling, regulatory approvals, and platform module expansion.
EU MDR & full FDA 510(k) clearance
Expansion to 50+ hospital systems globally
Development of 3 new specialty AI modules
International market penetration
$
10M
Series A (Projected)
Targeted capital for full commercial scaling, regulatory approvals, and platform module expansion.
EU MDR & full FDA 510(k) clearance
Expansion to 50+ hospital systems globally
Development of 3 new specialty AI modules
International market penetration
Ready to See the Full Picture?
This section contains proprietary information intended for potential investors.
Ready to See the Full Picture?
This section contains proprietary information intended for potential investors.
Ready to See the Full Picture?
This section contains proprietary information intended for potential investors.
Ready to See the Full Picture?
This section contains proprietary information intended for potential investors.